OPKO Health, Inc. (OPK) 13D/13G Filings for Entera Bio Ltd. (ENTX)

OPKO Health, Inc. 13D and 13G filings for Entera Bio Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-04-02
6:51 pm
Purchase
2025-03-16 13G Entera Bio Ltd.
ENTX
OPKO HEALTH INC.
OPK
3,685,226
8.100%
3,685,226increase
(New Position)
Filing